- Home
- KROS vs AXG Comparison
KROS vs AXG Comparison
Compare KROS & AXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KROS | AXG |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 763.8M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | KROS | AXG |
|---|---|---|
| Price | $17.73 | $4.02 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $22.20 | N/A |
| AVG Volume (30 Days) | 597.1K | ★ 685.1K |
| Earning Date | 02-25-2026 | 02-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $246,718,000.00 | $3,316,000.00 |
| Revenue This Year | $6,924.79 | $28.53 |
| Revenue Next Year | N/A | $54.60 |
| P/E Ratio | $11.38 | ★ N/A |
| Revenue Growth | ★ 37798.31 | N/A |
| 52 Week Low | $9.12 | $1.16 |
| 52 Week High | $22.55 | $5.09 |
Technical Indicators
Market Signals| Indicator | KROS | AXG |
|---|---|---|
| Relative Strength Index (RSI) | 35.45 | N/A |
| Support Level | $19.76 | N/A |
| Resistance Level | $21.76 | N/A |
| Average True Range (ATR) | 0.81 | 0.00 |
| MACD | -0.54 | 0.00 |
| Stochastic Oscillator | 5.18 | 0.00 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About AXG Solowin Holdings Class A Ordinary Share
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.